Emerging Pharmaceutical Markets - Potential & Problems: Industry Research Report

	Research Index \| Publishers \| My Account \| Contact Us \| About MindBranch
	Welcome Guest (Login/Register) \| 0 items

Advanced Search > | Tips >

Contact a
Research Assistant
US 800-774-4410
or +1-240-747-3094
Search Assistance >

Emerging Pharmaceutical Markets - Potential & Problems

Published Date: October 2001

Published By: Urch Publishing

Page Count: 255

Order Code: R410-114

Questions About This Report

E-mail a Colleague

Printable Page

Fax Your Order

Description

Table of Contents

Purchase
by the Section

Search Inside
this Report

Similar
Products

Drug regulators and representatives of the pharmaceutical industry from the US, Europe and Japan have been participating for nine years in the International Conference on Harmonisation (ICH). The purpose is to eliminate duplicative requirements for drug development and approval in the three regions, thus providing patients with more timely access to new medicines. The current major focus of ICH is development of a Common Technical Document that would form the basis for drug approval in the three regions.

Similar Products

• United States Type 2 Diabetes Market

Published Nov 2009 by Intellent

• Company Financials: Bayer AG

Published Nov 2009 by Datamonitor

• Thailand Pharmaceuticals and Healthcare Report Q1 2010

Published Nov 2009 by Business Monitor International

• Argentina Pharmaceuticals and Healthcare Report Q1 2010

Published Nov 2009 by Business Monitor International

• Takeda Pipeline, Products, Performance, Potential

Published Nov 2009 by Espicom Healthcare Intelligence

• Poland Pharmaceuticals and Healthcare Report Q1 2010